The Peter Attia Drive

Snapshot · The Peter Attia Drive

#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

Explore episode Jul 27, 2026

Where this was said

From Yellowstone hot springs to PCR: how Thermus aquaticus transformed modern biology and medicine

At 30:30 · chapter starts 28:00

In the mid-1960s, Thomas Brock at Indiana University began spending summers in Yellowstone National Park, motivated by a simple question the microbiology community had largely dismissed: could anything live in near-boiling water? The prevailing view held that 55°C was roughly the biological ceiling. Brock disagreed and started looking. At Octopus Spring, he found pink filamentous bacteria growing at 80–88°C. Working with undergraduate Hudson Freeze, he isolated and cultured these thermophilic organisms — no small feat at their preferred temperature — and published a 1969 paper describing Thermus aquaticus, which he deposited in public culture collections. Nearly 15 years later, Kary Mullis at Cetus Corporation conceived PCR: denature DNA by heating near boiling, cool to allow primers to bind, extend with polymerase, repeat. Each cycle doubles the DNA; after 30 cycles, one molecule becomes a billion copies. The problem: the E. coli-derived polymerases of the time fell apart at the required temperatures, demanding fresh enzyme after every cycle — a tedious, expensive, error-prone process even with a purpose-built robot. The solution was Taq polymerase, already sitting in public collections since 1969. With Taq, PCR became automated, scalable, and cheap. Mullis won the Nobel Prize in Chemistry in 1993. But the technique's existence depends entirely on Brock and Freeze's decision, decades earlier, to look for life in boiling water — work that was funded and published without anyone asking what disease it would cure.

Science
CRISPR: How Bacteria Invented Gene Editing 3 Billion Years Ago

#401 ‒ How curiosity transforms medicine: extraordinary dis… · Jul 27, 2026 Science

Francisco Mojica spent the entire 1990s trying to understand a bizarre repeating pattern in salt pond archaea DNA. His eventual discovery — that bacteria have an adaptive immune system that remembers past virus infections — was rejected by four top journals before publication. That system is now CRISPR, and it just received FDA approval as a therapy for sickle cell disease.

Similar snapshots